目标试验模拟与多状态模型分析,以使用临床COVID-19数据评估治疗有效性
Oksana Martinuka1, Derek Hazard2, Hamid Reza Marateb3
1Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Centre, University of Freiburg, Freiburg, Germany. oksana.martinuka@uniklinik-freiburg.de.
BMC medical research methodology
|September 2, 2023
概括
目标试验模拟与多州模型相结合,有效地使用现实数据评估COVID-19治疗方法,克服随机试验缺席时可靠证据的观察性研究中的偏见.
科学领域:
- 流行病学 流行病学
- 生物统计学 生物统计学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 现实世界的观察数据对于评估住院冠状病毒病2019 (COVID-19) 患者的治疗有效性至关重要.
- 纵向观测研究面临方法学偏差,包括不朽时间偏差,混和竞争风险,可能影响治疗有效性评估.
- 解决这些偏见对于从现实数据中生成可靠证据至关重要.
研究的目的:
- 利用现实世界的数据模拟目标试验,以评估单剂量COVID-19治疗的有效性.
- 描述一种将目标试验模拟与多状态模型相结合的方法,以解决观察数据的局限性.
- 评估住院COVID-19患者的临床严重性状况作为主要终点.
主要方法:
- 一组501名住院COVID-19患者的队列被用于目标试验模拟.
- 克隆-传感器-权重技术被应用于减轻不朽时间和时间固定混偏差.
- 用一个五个州的多州模型来估计治疗效果,用反向概率的审查权重来解决选择偏差.
主要成果:
- 试验模拟与多状态模型分析有效地解决了观测数据的局限性.
- 这种方法可以评估治疗对异质终点的影响,例如住院死亡和活着出院.
- 多态模型分析通过堆叠的概率图表来促进解释,包括ICU入院等中间状态.
结论:
- 将目标试验模拟与多状态模型分析相结合,为使用真实数据评估治疗有效性提供了一个强大的方法.
- 这种综合方法解决了不朽时间偏差,混偏差和竞争性风险事件.
- 这种方法为决策提供了宝贵的见解,特别是当随机对照试验数据无法获得时.
更多相关视频
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.7K
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
相关概念视频
01:16Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
01:20Comparing the Survival Analysis of Two or More Groups
222
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
222
01:16Crossover Experiments
2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K
01:21Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
01:20Study Designs in Epidemiology
264
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
264
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K